You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Research & Development
19 January 2021 - - US-based medical diagnostic products provider Cue Health Inc's molecular, point-of-care COVID-19 Tests are being distributed to five additional states, including Col...
19 January 2021 - The European Medicines Agency (EMA) has granted PRiority Medicines (PRIME) designation to Singapore-based Tessa Therapeutics' lead autologous CD30 CAR-T therapy intended for the...
18 January 2021 - Genkyotex SA revealed on Friday that its Phase 1 study in oral setanaxib demonstrated tolerance at the doses of up to 1600mg/day, with no safety signal or dose-limiting toxicity bein...
18 January 2021 - - The European Medicines Agency has granted PRiority MEdicines (PRIME) designation to US-based clinical-stage cell therapy company Tessa Therapeutics' lead autologous CD30 ...
18 January 2021 - - US-based healthcare company Johnson and Johnson's (NYSE: JNJ) Janssen Biotech, Inc. business has received US Food and Drug Administration approval of Darzalex Faspro (daratumu...
18 January 2021 - Luxembourg-based Steba biotech has received Fast Track designation from the United States Food and Drug Administration (FDA) for padeliporfin IMmune Photo Activate Cancer Treatment (...
Related Headlines
SML Genetree wins FDA's EUA for Ezplex SARS-CoV-2 G PCR Kit with specimen pooling capability
US FDA Clears Vor's IND Application for VOR33
PerkinElmer SARS-CoV-2 RT-PCR Assay Receives FDA EUA for Asymptomatic Testing
Twist Bioscience Begins Shipping of Synthetic RNA Controls for UK Variant Strain of SARS-CoV-2
Philippines FDA approves Pfizer-BioNTech COVID-19 vaccine for emergency use